| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/23/2010 | US7666422 Methods for the treatment of cancer using anti-CD40 antibodies |
| 02/23/2010 | US7666421 Comprising a variable region of nonhuman origin and at least a portion of an immunoglobulin of human origin; treating various autoimmune diseases, transplant rejection, inflammatory disorders and infectious diseases |
| 02/23/2010 | US7666420 Composition for treating pathology associated with MSRV/HERV-W |
| 02/23/2010 | US7666419 Anti-CCR5 antibody |
| 02/23/2010 | US7666418 Method for treating Th2-mediated disease |
| 02/23/2010 | US7666417 Such as rheumatoid arthritis and diabetes; antibodies; kits |
| 02/23/2010 | US7666415 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 02/23/2010 | US7666414 Using modified anti-PSMA antibodies, or fragments thereof, to bind to human PSMA with high affinity and specificity; can be used as diagnostic, prophylactic, or therapeutic agents in vivo and in vitro |
| 02/23/2010 | US7666413 For subcutaneous administration; hypertonic; useful for preventing self-association of reconstituted lyophilized formulations |
| 02/23/2010 | US7666412 Methods for the treatment of neoplastic disorders with anti-caveolin agents |
| 02/23/2010 | US7666411 Administering to the subject an effective amount of a substance that binds to IL-13, wherein the substance that binds to IL-13 is an antibody and inhibits IL-13 activation of IL-13R alpha |
| 02/23/2010 | US7666408 Virus-like particle of an RNA bacteriophage carrier attached to an angiotensin peptide through a nonpeptide bond to form an ordered and repetitive angiotensin peptide-carrier conjugate; treating/preventing hypertension, stroke, infarction, congestive heart failure, kidney failure and retinal hemorrhage |
| 02/23/2010 | US7666404 Glanders/meliodosis vaccines |
| 02/23/2010 | US7666389 Method of imaging cell death in vivo |
| 02/23/2010 | CA2355834C Human akt-3 |
| 02/23/2010 | CA2344173C Immunogenic liposome compositions |
| 02/23/2010 | CA2303390C Lkta deletion mutant of p. haemolytica |
| 02/23/2010 | CA2138999C Cloning and expression of gonadotropin-releasing hormone receptor |
| 02/20/2010 | CA2639003A1 Inhibition of fc.gamma.r-mediated phagocytosis with reduced immunoglobulin preparations |
| 02/18/2010 | WO2010019954A2 Purine nucleoside phosphorylase as enzymatic activator of nucleoside prodrugs |
| 02/18/2010 | WO2010019914A2 Anti-arrhythmia agents, methods of their use, methods for their identification, and kits thereofre |
| 02/18/2010 | WO2010019890A2 Vaccine for shigella |
| 02/18/2010 | WO2010019718A2 Carrier nanoparticles and related compositions, methods and systems |
| 02/18/2010 | WO2010019717A2 Combination therapy of hiv fusion/entry inhibitors targeting gp41 |
| 02/18/2010 | WO2010019702A2 Ddr1-binding agents and methods of use thereof |
| 02/18/2010 | WO2010019570A2 Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof |
| 02/18/2010 | WO2010019565A2 Anti-ephrin b2 antibodies and their use in treatment of disease |
| 02/18/2010 | WO2010019480A1 Attenuated herpesviruses encoding a mek pathway polypeptide |
| 02/18/2010 | WO2010019276A2 Method and formulation for treating adverse biological conditions |
| 02/18/2010 | WO2010019262A2 Polyvalent vaccine |
| 02/18/2010 | WO2010018846A1 Drug containing antibody composition specifically binding to ganglioside gm2 |
| 02/18/2010 | WO2010018384A1 T-cell antigen peptide from allergen for stimulation of il-10 production |
| 02/18/2010 | WO2010018378A2 Ragweed peptides for vaccine |
| 02/18/2010 | WO2010018207A1 Endoglin peptides, vaccines and methods for preparing the same |
| 02/18/2010 | WO2010018136A1 Minigene comprising htpa signal peptide, t-cell epitopes, e. coli ltb and furin sensitive linkers |
| 02/18/2010 | WO2010018003A2 Carrier system for biological agents containing organosilicon compounds and uses thereof |
| 02/18/2010 | WO2010017819A1 EFFICIENT CELL CULTURE SYSTEM FOR HEPATITIS C VIRUS GENOTYPE 7a |
| 02/18/2010 | WO2010017818A1 Efficient cell culture system for hepatitis c virus genotype 2b |
| 02/18/2010 | WO2010017598A1 Anti-il-12/il-23 antibodies |
| 02/18/2010 | WO2009126719A3 Commensal bacteria as signal mediators within a mammalian host |
| 02/18/2010 | WO2009126705A3 Induction of tumor hypoxia for cancer therapy |
| 02/18/2010 | WO2009120903A9 Cytokine receptors associated with myelogenous haematological proliferative disorders and uses thereof |
| 02/18/2010 | WO2009120801A3 Ikki inhibitor therapies and screening methods, and related ikki diagnostics |
| 02/18/2010 | WO2009114826A3 Treatment systems and methods for renal-related diseases |
| 02/18/2010 | WO2009082647A4 Recombinant rift valley fever (rvf) viruses and methods of use |
| 02/18/2010 | WO2009079259A3 Antibodies against influenza virus and methods of use thereof |
| 02/18/2010 | US20100043097 Brassinosteroid Regulated Kinases (BRKs) That Mediate Brassinosteroid Signal Transduction and Uses Thereof |
| 02/18/2010 | US20100041868 Conserved neisserial antigens |
| 02/18/2010 | US20100041587 Combination therapy for inhibition of platelet aggregation |
| 02/18/2010 | US20100041022 Novel assay for the separation and quantification of hemagglutinin antigens |
| 02/18/2010 | US20100041012 Rationally designed antibodies |
| 02/18/2010 | US20100040688 Hydrogel microparticle formation in aqueous solvent for biomedical applications |
| 02/18/2010 | US20100040676 Polycistronic hiv vector constructs |
| 02/18/2010 | US20100040675 Compositions and methods for promoting or inhibiting angiogenesis |
| 02/18/2010 | US20100040652 Live attenuated catfish vaccine and method of making |
| 02/18/2010 | US20100040651 Compositions and Methods for Vaccinating Against HSV-2 |
| 02/18/2010 | US20100040650 Virus-Like paramyxovirus particles and vaccines |
| 02/18/2010 | US20100040649 Inducible expression systems |
| 02/18/2010 | US20100040648 Plasmids with immunological action |
| 02/18/2010 | US20100040647 Vaccine |
| 02/18/2010 | US20100040646 Split-Core-Particles for the Presentation of Foreign Molecules, Especially for Vaccine Applications, and Method for their Production |
| 02/18/2010 | US20100040645 In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete domain and is cd4+ t cell-independent |
| 02/18/2010 | US20100040644 Methods for preparing immunogenic conjugates |
| 02/18/2010 | US20100040643 Flavivirus immunogens and methods of use |
| 02/18/2010 | US20100040642 Novel peptide adjuvant for influenza vaccination |
| 02/18/2010 | US20100040641 Peptide vaccines for cancers expressing tumor-associated antigens |
| 02/18/2010 | US20100040640 Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide |
| 02/18/2010 | US20100040639 Methods of inducing il-10 production |
| 02/18/2010 | US20100040638 Smoking cessation kit and method |
| 02/18/2010 | US20100040637 Methods and Composition for Treating Diseases Targeting Prominin-1 (CD133) |
| 02/18/2010 | US20100040636 Manipulation of Regulatory T Cell and Dc Function By Targeting Neuritin Gene Using Antibodies, Agonists and Antagonists |
| 02/18/2010 | US20100040635 Neutralizing antibodies to influenza viruses |
| 02/18/2010 | US20100040634 Methods and compositions for modulating hgf/met |
| 02/18/2010 | US20100040633 Binding compositions: related reagents |
| 02/18/2010 | US20100040632 Composition |
| 02/18/2010 | US20100040631 Combination Therapy of HIV Using Fusion/Entry Inhibitors Targeting GP41 |
| 02/18/2010 | US20100040630 Methods and compositions for treating bone loss |
| 02/18/2010 | US20100040629 Antibodies to c-Met |
| 02/18/2010 | US20100040628 Indoprofen derivatives for promoting bone growth |
| 02/18/2010 | US20100040627 Baff receptor (bcma), an immunoregulatory agent |
| 02/18/2010 | US20100040626 Methods for detecting and treating attention-deficit/hyperactivity disorder |
| 02/18/2010 | US20100040625 Pharmaceutical Compositions Containing Monoclonal Anti-Idiotypic Anti-Ca-125 Antibody and Aluminium Derivatives |
| 02/18/2010 | US20100040624 Human Tumor Necrosis Factor TR21 and Methods Based Thereon |
| 02/18/2010 | US20100040623 Neuritogenic and neuronal survival promoting peptides derived from the family of s-100 proteins |
| 02/18/2010 | US20100040622 Netrin-related compositions and uses |
| 02/18/2010 | US20100040621 Novel polpeptide and use thereof |
| 02/18/2010 | US20100040620 ANTI-CANCER ANTIBODIES AGAINST LEWISy AND LEWISb ANTIGENS |
| 02/18/2010 | US20100040619 antibodies and antigen binding domains and CDR regions that mediate selective binding to an epitope located in the carboxyl half of the Dkk-1 protein; for bone disorders, inflammatory, neurological, ocular, renal, pulmonary and skin diseases |
| 02/18/2010 | US20100040618 Prevention of tumors with monoclonal antibodies against neu |
| 02/18/2010 | US20100040617 Method of Using CD100 (or Sema4D) to Mediate Platelet Activation and Inflammatory Responses |
| 02/18/2010 | US20100040616 Treatment of autoimmune and inflammatory disease |
| 02/18/2010 | US20100040615 Digalactolipidic Antigen Exposed on the Surface of Apicomplex Parasites, and Diagnostic and Therapeutic Use Thereof |
| 02/18/2010 | US20100040614 Compositions and methods for the treatment of infections and tumors |
| 02/18/2010 | US20100040613 Polypeptide constructs for sublingual administration |
| 02/18/2010 | US20100040612 Methods and compositions for reducing amyloid beta levels |
| 02/18/2010 | US20100040611 Antagonists of pcsk9 |
| 02/18/2010 | US20100040610 Antagonists of pcsk9 |
| 02/18/2010 | US20100040609 Methods for preventing, postponing or improving the outcome of invasive spinal procedures |
| 02/18/2010 | US20100040608 Use of HMGB1 antagonists for the treatment of inflammatory skin conditions |
| 02/18/2010 | US20100040607 Combination Therapy with Inhibitors of HMGB and Caspase for the Treatment of Inflammatory Diseases |